• Home
  1. Home
  2. Failures in clinical treatment of Staphylococcus aureus Infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding
Scientific article
English

Failures in clinical treatment of Staphylococcus aureus Infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding

Contributors

Jones, Tiffanny; Yeaman, Michael R.; Sakoulas, George; Yang, Soo-Jin; Proctor, Richard A.; Sahl, Hans-Georg; Schrenzel, Jacques; Xiong, Yan Q.; Bayer, Arnold S.

Published in

Antimicrobial agents and chemotherapy, vol. 52, no. 1, p. 269-278

Publication date

2008

Abstract

Increasingly frequent reports have described the in vivo loss of daptomycin susceptibility in association with clinical treatment failures. The mechanism(s) of daptomycin resistance is not well understood. We studied an isogenic set of Staphylococcus aureus isolates from the bloodstream of a daptomycin-treated patient with recalcitrant endocarditis in which serial strains exhibited decreasing susceptibility to daptomycin. Since daptomycin is a membrane-targeting lipopeptide, we compared a number of membrane parameters in the initial blood isolate (parental) with those in subsequent daptomycin-resistant strains obtained during treatment. In comparison to the parental strain, resistant isolates demonstrated (i) enhanced membrane fluidity, (ii) increased translocation of the positively charged phospholipid lysyl-phosphotidylglycerol to the outer membrane leaflet, (iii) increased net positive surface charge (P < 0.05 versus the parental strain), (iv) reduced susceptibility to daptomycin-induced depolarization, permeabilization, and autolysis (P < 0.05 versus the parental strain), (v) significantly lower surface binding of daptomycin (P < 0.05 versus the parental strain), and (vi) increased cross-resistance to the cationic antimicrobial host defense peptides human neutrophil peptide 1 (hNP-1) and thrombin-induced platelet microbicidal protein 1 (tPMP-1). These data link distinct changes in membrane structure and function with in vivo development of daptomycin resistance in S. aureus. Moreover, the cross-resistance to hNP-1 and tPMP-1 may also impact the capacity of these daptomycin-resistant organisms to be cleared from sites of infection, particularly endovascular foci.

Keywords

  • *Anti-Bacterial Agents/metabolism/pharmacology/therapeutic use
  • *Cell Membrane/chemistry/metabolism/physiology
  • Cell Membrane Permeability
  • *Daptomycin/metabolism/pharmacology/therapeutic use
  • *Drug Resistance, Bacterial
  • Humans
  • Microbial Sensitivity Tests
  • Phospholipids/analysis
  • Staphylococcal Infections/*drug therapy/microbiology
  • Staphylococcus aureus/*drug effects
  • Treatment Failure

UNIGE affiliation entities

UNIGE research groups

Citation (ISO format)

JONES, Tiffanny et al. Failures in clinical treatment of Staphylococcus aureus Infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding. In: Antimicrobial agents and chemotherapy, 2008, vol. 52, n° 1, p. 269–278. doi: 10.1128/AAC.00719-07

Main files (1)

Article (Published version)

Identifiers

Additional URL for this publication

http://aac.asm.org/content/52/1/269.full.pdf

Journal ISSN

0066-4804
541views
0downloads

Technical informations

Creation

27/03/2012 09:23:08

First validation

27/03/2012 09:23:08

Update

13/01/2025 13:58:36

Status update

13/01/2025 13:58:36

Last indexation

13/01/2025 14:07:44
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated